Thaís Helena Proença de Freitas

Thaís Helena Proença de Freitas

Auto-generated profile, based on publicly available information

Thaís Helena Proença de Freitas

Santa Casa Medical and Hospital School, Dermatology Clinic, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
PDF file
EBEdileia Bagatin
Edileia Bagatin
TFThais Helena Proença de Freitas
Thais Helena Proença de Freitas
MRMaria Cecilia Rivitti-Machado
Maria Cecilia Rivitti-Machado
BRBeatriz Medeiros Ribeiro
Beatriz Medeiros Ribeiro
SNSamanta Nunes
Samanta Nunes
MRMARCO A D ROCHA
MARCO A D ROCHA
Keywords: Acne vulgaris; Adult; Advanced treatment; Consensus; Hormones; Hyperandrogenism; Skin; Therapeutics

12 May 2021 in Expert Review of Clinical Pharmacology
Verified
Journal Article
Closed access
EBEdileia Bagatin
Edileia Bagatin
MRMARCO A D ROCHA
MARCO A D ROCHA
TFThais Helena Proença Freitas
Thais Helena Proença Freitas
CCCaroline Sousa Costa
Caroline Sousa Costa
Introduction: Acne is a chronic, inflammatory, and immune-mediated disease of the pilosebaceous unit, highly prevalent in adolescents. However, an increasing number of adults over 25 years old with facial acne, particularly women, have been observed. It is considered a different disease when compared to acne vulgaris. Face is the mainly involved area with inflammatory lesions and more sensitive skin, pointing out the need of a holistic approach. Areas covered: We performed a comprehensive literature search on PubMed database, up to January 2021, regarding adult female acne. We synthesized data about pathogenesis; differences compared to acne vulgaris; and treatment, with focus in the management challenges and perspectives. Expert opinion: It is essential to value the negative impact on quality of life of adult female acne, independently of severity. The disease has prolonged evolution, and patient might be resilient once the improvement, regardless of the treatment option, will just be noticeable after 3 months. Aggravating factors should be clearly discussed, such as the need of changing many habits, especially lesions manipulation. The therapeutic regimen includes make-up and tailored skin care (considering proneness to sensitivity), while anti-acne drugs should be chosen in accordance with desire to be pregnant, presence of pregnancy or breastfeeding.

1 July 2020 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
JVJohn Verrinder Veasey
John Verrinder Veasey
RZRICARDO ZAMPIERI
RICARDO ZAMPIERI
RLRute Facchini Lellis
Rute Facchini Lellis
TFThaís Helena Proença de Freitas
Thaís Helena Proença de Freitas
Lucile M WinterLucile M Winter
Lucile M Winter
American cutaneous leishmaniasis is an infectious dermatosis caused by protozoa of the genus Leishmania, which comprises a broad spectrum of clinical manifestations depending on the parasite species involved in the infections and the immunogenetic response of the host. The use of techniques for amplification of the parasites DNA based on polymerase chain reaction polymerase chain reaction and the recent application of combined techniques, such as high-resolution DNA dissociation, have been described as a viable alternative for the detection and identification of Leishmania spp. in biological samples. To identify the Leishmania species using the polymerase chain reaction high-resolution DNA dissociation technique in skin biopsies of hospital-treated patients, and compare with results obtained by other molecular identification techniques. A retrospective study assessing patients with suspected American cutaneous leishmaniasis seen at a hospital in São Paulo/Brazil was conducted. The paraffin blocks of 22 patients were analyzed by polymerase chain reaction high-resolution DNA dissociation to confirm the diagnosis and identify the species. Of the 22 patients with suspected American cutaneous leishmaniasis, the parasite was identified in 14, comprising five cases (35.6%) of infection by L. amazonensis, four (28.5%) by L. braziliensis, two (14.4%) by L. amazonensis+L. infantum chagasi, two (14.4%) by L. guyanensis, and one (7.1%) by Leishmania infantum chagasi. In one of the samples, in which the presence of amastigotes was confirmed on histopathological examination, the polymerase chain reaction high-resolution DNA dissociation technique failed to detect the DNA of the parasite. The retrospective nature of the study and small number of patients. The method detected and identified Leishmania species in paraffin-embedded skin biopsies with a sensitivity of 96.4% and could be routinely used in the public health system.

1 July 2020 in Anais Brasileiros de Dermatologia (Versão em Português)
Verified
Journal Article
Open access
JVJohn Verrinder Veasey
John Verrinder Veasey
RZRICARDO ZAMPIERI
RICARDO ZAMPIERI
RLRute Facchini Lellis
Rute Facchini Lellis
TFThaís Helena Proença de Freitas
Thaís Helena Proença de Freitas
Lucile M WinterLucile M Winter
Lucile M Winter